STERIS’ (TSE:STE – Get Rating) – Investment analysts at Atb Cap Markets decreased their Q3 2023 EPS estimates for STERIS’ in a report issued on Thursday, May 11th. Atb Cap Markets analyst W. Syed now expects that the company will earn $0.26 per share for the quarter, down from their prior forecast of $0.27. Atb Cap Markets also issued estimates for STERIS’’s Q4 2024 earnings at $0.23 EPS and FY2024 earnings at $1.12 EPS.
STERIS’ Price Performance
STERIS’ (TSE:STE – Get Rating) last posted its quarterly earnings results on Wednesday, March 1st. The company reported C$0.23 earnings per share for the quarter, missing analysts’ consensus estimates of C$0.29 by C($0.06). The firm had revenue of C$251.39 million for the quarter, compared to the consensus estimate of C$249.77 million.
STERIS’ Company Profile
STERIS’s MISSION IS TO HELP OUR CUSTOMERS CREATE A HEALTHIER AND SAFER WORLD by providing innovative healthcare and life science product and service solutions around the globe by providing innovative healthcare and life science product and service solutions around the globe.
- MarketBeat Week in Review – 5/8 – 5/12
- An Updraft Is Brewing For DraftKings
- PepsiCo Hits “Sweet Spot” For APAC Growth, Macros Agree
- High-Risk Mullen Automotive Continues To Build Momentum
- 3 Recession-Proof Stocks With Nice Dividends
Receive News & Ratings for STERIS’ Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for STERIS’ and related companies with MarketBeat.com's FREE daily email newsletter.